Literature DB >> 11471900

Serum tumor markers: past, state of the art, and future.

C M Thomas1, C G Sweep.   

Abstract

Serum determinations of tumor markers are indispensable in the diagnosis and management of cancer, and therefore play an important role in clinical practice. After a short historical survey, we systematically review a number of contemporary aspects of serum tumor markers related to various organ systems, and briefly indicate possible future developments.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11471900

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN： 0393-6155            Impact factor:   2.659


  7 in total

1.  [Clinical utility of serous tumoural markers].

Authors:  A Martín Suárez; L Alonso Díaz; I Ordiz Alvarez; J Vázquez; F Vizoso Piñeiro
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

2.  Biomarkers for hepatocellular carcinoma.

Authors:  Goshi Shiota; Norimasa Miura
Journal:  Clin J Gastroenterol       Date:  2012-04-26

3.  The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors.

Authors:  Bing Wang; Qingyun Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-26       Impact factor: 4.553

4.  Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.

Authors:  Wen-Wei Zhu; Jia-Jian Guo; Lei Guo; Hu-Liang Jia; Ming Zhu; Ju-Bo Zhang; Christopher A Loffredo; Marshonna Forgues; Hua Huang; Xu-Jian Xing; Ning Ren; Qiong-Zhu Dong; Hai-Jun Zhou; Zheng-Gang Ren; Nai-Qing Zhao; Xin Wei Wang; Zhao-You Tang; Lun-Xiu Qin; Qing-Hai Ye
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

5.  Expression of two basic mRNA biomarkers in peripheral blood of patients with non-small cell lung cancer detected by real-time rt-PCR, individually and simultaneously.

Authors:  Shirin Karimi; Abdolreza Mohamadnia; Seyed Alireza Nadji; Reza Yadegarazari; Adnan Khosravi; Naghmeh Bahrami; Massoud Saidijam
Journal:  Iran Biomed J       Date:  2015

6.  Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?

Authors:  Ana L Teixeira; Francisca Dias; Mónica Gomes; Mara Fernandes; Rui Medeiros
Journal:  J Kidney Cancer VHL       Date:  2014-12-24

7.  The Frequency of Epidermal Growth Factor Receptor (EGFR) Mutation in Patients with Lung Adenocarcinoma Referred to a Lung Diseases Hospital; A Cross-Sectional Study from Iran.

Authors:  Sotoudeh Mohammadi; Mitra Rezaei; Fatemeh Shojaeian; Mihan Pourabdollah; Leila Mohammadi Ziazi; Sharareh Seifi; Atousa Doroudinia; Babak Salimi; Adnan Khosravi; Mohammad Amin Farhangnasab
Journal:  Iran J Pathol       Date:  2022-02-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.